Skip Navigation

Rheumatology 2008 47(1):31-35; doi:10.1093/rheumatology/kem289
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Valvason, C.
Right arrow Articles by Punzi, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Valvason, C.
Right arrow Articles by Punzi, L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Influence of glucosamine sulphate on oxidative stress in human osteoarthritic chondrocytes: effects on HO-1, p22Phox and iNOS expression

C. Valvason1, E. Musacchio2, A. Pozzuoli3, R. Ramonda1, R. Aldegheri3 and L. Punzi1

1Rheumatology Unit, Department of Clinical and Experimental Medicine, 2Clinica Medica I, Department of Medical and Surgical Sciences and 3Department of Medical and Surgical Specialties, Orthopaedic Clinic, University of Padova, Italy.

Correspondence to: L. Punzi, Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Padova, Via Giustiniani, 2-35128 Padova, Italy. E-mail: punzireu{at}unipd.it


   Abstract

Objective. Reactive oxygen species (ROS) are major determinants in the alteration of articular cartilage. Among protective cellular mechanisms, the inducible isoform of haem oxygenase (HO-1) plays a particularly relevant role. On the other hand, the enzymatic activity of the Nicotinamide adenine dinucleotide phosphate (NADPH) system could contribute to the generation of ROS. Glucosamine sulphate (GS) is one of the drugs used in the treatment of osteoarthritis; however, its mechanism of action is still largely unknown. The aim of the present study was to investigate the effects of GS on primary human chondrocytes in vitro, in particular with regard to HO-1, p22Phox (a subunit of NADPH complex) and inducible nitric oxide synthase (iNOS) expression.

Methods. Primary human chondrocytes were treated with different concentrations of GS; gene expression of HO-1, p22Phox and iNOS was assessed by the reverse transcriptase–polymerase chain reaction method. In a separate set of experiments, the cells were stimulated with human recombinant interleukin (IL)-1β and simultaneously treated with GS. Moreover, HO-1 protein and total nitrite production were evaluated.

Results. HO-1 gene expression was up-regulated (+40% with respect to the controls, P < 0.001) by 10 mmol/l GS at 24 h, while p22Phox gene expression was down-regulated by 10 mmol/l GS with a maximum inhibitory effect observed after 48 h treatment. IL-1β stimulation induced expression of iNOS reverted by 1 and 10 mmol/l GS. Moreover, HO-1 gene expression was down-regulated by IL-1β and 10 mmol/l GS restored baseline values. These data were confirmed by evaluating HO-1 protein level and nitrite production.

Conclusions. The influence of GS on oxidative stress observed in this study discloses a possible new mechanism of action and seems to be in keeping with a potential protective effect on chondrocyte population.

KEY WORDS: Glucosamine sulphate, Osteoarthritis, Chondrocytes, Haemoxygenase, p22Phox

Submitted 15 January 2007; revised version accepted 20 July 2007.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.